1 Min Read
Feb 10 (Reuters) - Rigel Pharmaceuticals Inc
* Great Point Partners LLC reports 7.47 passive stake in Rigel Pharmaceuticals Inc as on January 31, 2017 - SEC filing Source text (bit.ly/2kAJjwK) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.